Origène Nyanguile

1.1k total citations
17 papers, 739 citations indexed

About

Origène Nyanguile is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Origène Nyanguile has authored 17 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Oncology. Recurrent topics in Origène Nyanguile's work include Hepatitis C virus research (5 papers), HIV/AIDS drug development and treatment (4 papers) and Virus-based gene therapy research (3 papers). Origène Nyanguile is often cited by papers focused on Hepatitis C virus research (5 papers), HIV/AIDS drug development and treatment (4 papers) and Virus-based gene therapy research (3 papers). Origène Nyanguile collaborates with scholars based in United States, Switzerland and France. Origène Nyanguile's co-authors include Gregory L. Verdine, Motonari Uesugi, Arnold J. Levine, Hua Lu, David Austin, Pierre Raboisson, Carlo Boutton, Ivan S. Alferiev, Richard S. Gaster and Robert J. Levy and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Gastroenterology.

In The Last Decade

Origène Nyanguile

17 papers receiving 718 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Origène Nyanguile United States 13 447 143 125 115 94 17 739
Thorsten Kirschberg United States 14 665 1.5× 129 0.9× 78 0.6× 216 1.9× 219 2.3× 24 1.0k
Zhilei Chen United States 15 451 1.0× 85 0.6× 74 0.6× 70 0.6× 100 1.1× 41 808
Nikos Pagratis United States 15 430 1.0× 100 0.7× 101 0.8× 39 0.3× 92 1.0× 30 668
Kerstin Jahn‐Hofmann Germany 16 693 1.6× 233 1.6× 115 0.9× 34 0.3× 53 0.6× 26 1.0k
Darren H. Wakefield United States 9 842 1.9× 149 1.0× 87 0.7× 51 0.4× 41 0.4× 10 997
Eckart Matthes Germany 16 356 0.8× 196 1.4× 59 0.5× 69 0.6× 297 3.2× 43 701
Yi-Ting Cheng United States 16 590 1.3× 229 1.6× 51 0.4× 89 0.8× 188 2.0× 29 1.1k
Lyle Burdine United States 14 386 0.9× 61 0.4× 97 0.8× 137 1.2× 23 0.2× 37 708
Dieter Vanderschaeghe Belgium 14 422 0.9× 188 1.3× 79 0.6× 98 0.9× 57 0.6× 21 739
Marees Harris-Brandts Canada 6 474 1.1× 68 0.5× 70 0.6× 81 0.7× 34 0.4× 6 634

Countries citing papers authored by Origène Nyanguile

Since Specialization
Citations

This map shows the geographic impact of Origène Nyanguile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Origène Nyanguile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Origène Nyanguile more than expected).

Fields of papers citing papers by Origène Nyanguile

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Origène Nyanguile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Origène Nyanguile. The network helps show where Origène Nyanguile may publish in the future.

Co-authorship network of co-authors of Origène Nyanguile

This figure shows the co-authorship network connecting the top 25 collaborators of Origène Nyanguile. A scholar is included among the top collaborators of Origène Nyanguile based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Origène Nyanguile. Origène Nyanguile is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Postupalenko, Viktoriia, Léo Marx, David Viertl, et al.. (2023). Site-selective template-directed synthesis of antibody Fc conjugates with concomitant ligand release. Chemical Science. 15(4). 1324–1337. 10 indexed citations
2.
Postupalenko, Viktoriia, Léo Marx, David Viertl, et al.. (2022). Template directed synthesis of antibody Fc conjugates with concomitant ligand release. Chemical Science. 13(14). 3965–3976. 11 indexed citations
3.
Galloux, Marie, Thibaut Larcher, Marthe Vilotte, et al.. (2020). Targeting the Respiratory Syncytial Virus N 0 -P Complex with Constrained α-Helical Peptides in Cells and Mice. Antimicrobial Agents and Chemotherapy. 64(10). 8 indexed citations
4.
Nyanguile, Origène. (2019). Peptide Antiviral Strategies as an Alternative to Treat Lower Respiratory Viral Infections. Frontiers in Immunology. 10. 1366–1366. 28 indexed citations
5.
Galloux, Marie, Dominique Garcin, Jean‐François Eléouët, et al.. (2017). A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading. Antimicrobial Agents and Chemotherapy. 61(4). 32 indexed citations
6.
Devogelaere, Benoit, Jan Martin Berke, Leen Vijgen, et al.. (2012). TMC647055, a Potent Nonnucleoside Hepatitis C Virus NS5B Polymerase Inhibitor with Cross-Genotypic Coverage. Antimicrobial Agents and Chemotherapy. 56(9). 4676–4684. 31 indexed citations
7.
Lenz, Oliver, Jan Martin Berke, Herman de Kock, et al.. (2010). 759 COMBINATION OF TMC435 WITH TWO NOVEL NS5B INHIBITORS INCREASES ANTI HCV ACTIVITY AND RESULTS IN A HIGHER GENETIC BARRIER IN VITRO. Journal of Hepatology. 52. S295–S296. 2 indexed citations
8.
Vandyck, Koen, Maxwell D. Cummings, Origène Nyanguile, et al.. (2009). Structure-Based Design of a Benzodiazepine Scaffold Yields a Potent Allosteric Inhibitor of Hepatitis C NS5B RNA Polymerase. Journal of Medicinal Chemistry. 52(14). 4099–4102. 50 indexed citations
9.
Liang, Yuqiong, Hisashi Ishida, Oliver Lenz, et al.. (2008). Antiviral Suppression vs Restoration of RIG-I Signaling by Hepatitis C Protease and Polymerase Inhibitors. Gastroenterology. 135(5). 1710–1718.e2. 39 indexed citations
10.
Nyanguile, Origène, Frederik Pauwels, Carlo Boutton, et al.. (2008). 1,5-Benzodiazepines, a Novel Class of Hepatitis C Virus Polymerase Nonnucleoside Inhibitors. Antimicrobial Agents and Chemotherapy. 52(12). 4420–4431. 37 indexed citations
11.
Pauwels, Frederik, Wendy Mostmans, Liesbet van der Helm, et al.. (2007). Binding-Site Identification and Genotypic Profiling of Hepatitis C Virus Polymerase Inhibitors. Journal of Virology. 81(13). 6909–6919. 55 indexed citations
12.
Chorny, Michael, Ilia Fishbein, Ivan S. Alferiev, et al.. (2006). Adenoviral Gene Vector Tethering to Nanoparticle Surfaces Results in Receptor-Independent Cell Entry and Increased Transgene Expression. Molecular Therapy. 14(3). 382–391. 22 indexed citations
13.
Fishbein, Ilia, Ivan S. Alferiev, Origène Nyanguile, et al.. (2005). Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents. Proceedings of the National Academy of Sciences. 103(1). 159–164. 70 indexed citations
14.
Nyanguile, Origène, et al.. (2003). Synthesis of adenoviral targeting molecules by intein-mediated protein ligation. Gene Therapy. 10(16). 1362–1369. 15 indexed citations
15.
Xu, Ling, et al.. (2001). A Versatile Framework for the Design of Ligand-Dependent, Transgene-Specific Transcription Factors. Molecular Therapy. 3(2). 262–273. 21 indexed citations
16.
Nyanguile, Origène, Motonari Uesugi, David Austin, & Gregory L. Verdine. (1997). A nonnatural transcriptional coactivator. Proceedings of the National Academy of Sciences. 94(25). 13402–13406. 56 indexed citations
17.
Uesugi, Motonari, Origène Nyanguile, Hua Lu, Arnold J. Levine, & Gregory L. Verdine. (1997). Induced α Helix in the VP16 Activation Domain upon Binding to a Human TAF. Science. 277(5330). 1310–1313. 252 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thorsten Kirschberg Breakdown of academic impact, for papers by Zhilei Chen Breakdown of academic impact, for papers by Nikos Pagratis Breakdown of academic impact, for papers by Kerstin Jahn‐Hofmann Breakdown of academic impact, for papers by Darren H. Wakefield Breakdown of academic impact, for papers by Eckart Matthes Breakdown of academic impact, for papers by Yi-Ting Cheng Breakdown of academic impact, for papers by Lyle Burdine Breakdown of academic impact, for papers by Dieter Vanderschaeghe Breakdown of academic impact, for papers by Marees Harris-Brandts
Rankless by CCL
2026